Non-alcoholic fatty liver disease, metabolic syndrome and gastric cancer: Single center experience

Journal of B.U.ON.

Volumn 20, Issue 2, 2015, Pages 662-

  Uzel, Mehmet ^a   Sahiner, Zeynep ^a   Filik, Levent ^a  

^a Ankara Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

CARCINOGENESIS; COLORECTAL CANCER; CORONARY ARTERY ATHEROSCLEROSIS; ESOPHAGOGASTROSCOPY; GASTROSCOPY; HUMAN; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PREVALENCE; STOMACH CANCER; AGED; COMPLICATION; FEMALE; MALE; MIDDLE AGED; STOMACH NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; STOMACH NEOPLASMS;

EID: 84930745015     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA 2001; 285:2486-2497.
2. Williams CD, Stengel J, Asike MI et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 2011; 140:124-131.
3. Touzin NT, Bush KNV, Williams CD, Harrison SA. Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease, Therap Adv Gastroenterol 2011; 4:169-176.
4. Ferroni P, Palmirotta R, Spila A et al. Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res 2007; 27:483-489.
5. Jinjuvadia R, Lohia P, Jinjuvadia C., Montoya S, Liangpun-sakul S. The Association Between Metabolic Syndrome and Colorectal Neoplasm: Systemic Review and Meta-analysis. J Clin Gastroenterol 2013; 47:33-44.